A new agreement between the Trump administration and drug manufacturer Pfizer will exempt the giant from proposed pharmaceutical tariffs in exchange for allegedly cutting price  for American consumers. The deal has inspired Trump to declare victory over Pfizer, telling CEO Albert Bourla, “I’m surprised you’re agreeing to this.” However, on closer inspection, the deal appears to […]

This post was originally published on Jacobin.